ArticleBladder cancer (Amsterdam, Netherlands)

Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma.

Nobutaka Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.